Connect to Protect Partnerships for Youth Prevention Interventions: Phase II
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is Phase II of a three stage project whose overall goals are to develop viable community-based HIV prevention interventions and to form and maintain the necessary community collaborations to support such Adolescent Trials Network (ATN) research activities.
This phase will describe specific locations within high-risk areas where youth, ages 12-24, spend time. HIV risk behaviors, social networking patterns and HIV prevalence among youth at these venues will be assessed by administering anonymous computerized interviews to eligible and willing youth. This information will be shared with community partners during scheduled working group meetings.
| Condition |
|---|
|
HIV Infection |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Official Title: | Connect to Protect (C2P) Partnerships for Youth Prevention Interventions: Phase II |
| Estimated Enrollment: | 1500 |
| Study Start Date: | September 2003 |
| Estimated Study Completion Date: | September 2006 |
This is Phase II of a three stage project whose overall goals are to develop viable community-based HIV prevention interventions and to form and maintain the necessary community collaborations to support such ATN research activities.
During this phase, each ATN site will gather additional information within high-risk areas and solicit community partner input to ultimately pinpoint the specific locations where at-risk youths, ages 12-24, may be recruited for interventions. This will be done by the following methods:
Venues will be identified by HIV+ youth at the ATN site by participation in an anonymous computerized interview. Site staff will then perform brief venue interviews (BVIs) at selected venues to assess the potential yield of youths 12-24 years old. Community partners will also provide the site staff with information on known high-risk venues. High-risk venues will further be identified by the results of anonymous computerized interviews and HIV assays obtained from eligible and willing youth participants at the venues. The interviews will gather information on HIV risk behaviors, social networking patterns and HIV prevalence among youths at these venues. This information will be shared with community partners during scheduled working group meetings.
Eligibility| Ages Eligible for Study: | 12 Years to 24 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Index Subjects:
- Documented HIV-infection
- Acquisition of HIV after age 9 years
- Verbal confirmation of 12-24 years of age
- Verbal report of having engaged in sexual activity (vaginal, anal and/or oral sex) within the past 12 months
- Ability to understand and willingness to provide informed consent/assent
BVI subjects:
- Youths who appear to be 12-24 years old
HIV Serosurvey subjects at the venues:
- Verbal confirmation of 12-24 years of age
- Verbal report of having engaged in sexual activity (vaginal, anal and/or oral sex) within the past 12 months
- Ability to understand and willingness to provide informed consent/assent
Exclusion Criteria:
- Visibly distraught and/or emotionally unstable (i.e. depressive mood, exhibiting manic, suicidal or violent behavior, etc.)
- Visibly intoxicated or under the influence of psychoactive agents
- Clinically presents as acutely ill
Contacts and Locations| United States, California | |
| Childrens Hospital of Los Angeles | |
| Los Angeles, California, United States, 90054 | |
| UCSD Mother, Child & Adolescent HIV Program | |
| San Diego, California, United States, 92103 | |
| Univ of Califormia at San Francisco | |
| San Francisco, California, United States, 94143 | |
| United States, District of Columbia | |
| Children's Hospital National Medical Center | |
| Washington, District of Columbia, United States, 20010 | |
| United States, Florida | |
| Children's Diag. and Treatment Center | |
| Ft. Lauderdale, Florida, United States, 33301 | |
| University of Miami | |
| Miami, Florida, United States, 33101 | |
| USF Peds Div. of Infectious Disease | |
| Tampa, Florida, United States, 33606 | |
| United States, Illinois | |
| Stroger Hospital of Cook County | |
| Chicago, Illinois, United States, 60612 | |
| United States, Louisiana | |
| Tulane Medical Center | |
| New Orleans, Louisiana, United States, 70112 | |
| United States, Maryland | |
| University of Maryland | |
| Baltimore, Maryland, United States, 21201 | |
| United States, Massachusetts | |
| Childrens' Hospital of Boston | |
| Boston, Massachusetts, United States, 02115 | |
| United States, New York | |
| Montefiore Medical Center, Adolescent AIDS Program | |
| Bronx, New York, United States, 10467 | |
| Mount Sinai Medical Center | |
| New York, New York, United States, 10128 | |
| United States, Pennsylvania | |
| Children's Hopsital of Philadelphia | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Puerto Rico | |
| University Pediatric Hospital | |
| San Juan, Puerto Rico, 00936 | |
| Study Chair: | Jonathan Ellen, MD | Johns Hopkins Medical Center |
| Principal Investigator: | Ligia Peralta, MD | Division of Adolescent & Young Adult Medicine University of MD, Medical School |
| Principal Investigator: | Donna Futterman, MD | Montefiore Medical Center |
| Principal Investigator: | Marvin Belzer, MD | Childrens Hosp of Los Angeles, Division of Adolescent Medicine |
| Principal Investigator: | Bret Rudy, MD | Children's Hospital of Philadelphia |
| Principal Investigator: | Larry D'Angelo, MD | Children's Research Institute |
| Principal Investigator: | Cathryn Samples, MD | Children's Hospital Boston |
| Principal Investigator: | Lisa Henry-Reid, MD | John H. Stroger Jr. Hospital and the CORE Center |
| Principal Investigator: | Ana Puga, MD | Children’s Diag. and Treatment Ctr of Ft. Lauderdale, FL |
| Principal Investigator: | Lawrence Friedman, MD | University of Miami, School of Medicine, Div of Adolescent Medicine |
| Principal Investigator: | Patricia Emmanuel, MD | University of South Florida, Peds Div of Infectious Disease |
| Principal Investigator: | Sue Ellen Abdalian, MD | Tulane Medical Center |
| Principal Investigator: | Linda Levin, MD | Mount Sinai Adolescent Health Center |
| Principal Investigator: | Irma Febo, MD | University of Puerto Rico, Medical Sciences Campus |
| Principal Investigator: | Stephen A Spector, MD | UCSD Mother, Child, & Adolescent HIV Program |
| Principal Investigator: | Rolando M Viani, MD | UCSD Mother, Child, & Adolescent HIV Program |
| Principal Investigator: | Barbara Moscicki, MD | UCSF, Division of Adoles. Med |
| Principal Investigator: | Coco Auerswald, MD | UCSF, Division of Adoles. Med |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00103896 History of Changes |
| Other Study ID Numbers: | ATN 016b |
| Study First Received: | February 15, 2005 |
| Last Updated: | July 16, 2007 |
| Health Authority: | United States: Federal Government |
Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
|
High-risk youth HIV infected youth Community mobilization HIV serosurveys |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 16, 2013